Initial data associating ID1 and ID3 with cancer emerged from studies of xenografts and spontaneous tumors in genetically engineered mouse models, which typically showed decreased tumor growth and impaired angiogenesis in Id1- and/or Id3-deficient backgrounds1,4,5. The gene discussed is ID3; the disease is neoplasm.